Alzheimer's Disease

Showing NaN - NaN of 87

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Alzheimer's Disease Trial in United States (MK-8189, Placebo)

Completed
  • Alzheimer's Disease
  • Santa Ana, California
  • +7 more
Jan 19, 2023

Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)

Completed
  • Alzheimer's Disease
  • PF-04360365 0.1 mg/kg
  • +5 more
  • Peoria, Arizona
  • +41 more
Oct 11, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Active, not recruiting
  • Alzheimer's Disease
  • Garden Grove, California
  • +48 more
Sep 1, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Sun City, Arizona
  • +115 more
Aug 18, 2022

Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)

Recruiting
  • Alzheimer's Disease
  • Remternetug (IV)
  • +2 more
  • Chandler, Arizona
  • +70 more
Aug 10, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)

Completed
  • Alzheimer's Disease
  • Sun City, Arizona
  • +130 more
May 23, 2022

Alzheimer's Disease Trial in United States (TB006, Placebo)

Active, not recruiting
  • Alzheimer's Disease
  • Garden Grove, California
  • +17 more
May 29, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +132 more
Feb 16, 2022

Alzheimer's Disease Trial in Delray Beach, Miami (Longeveron Mesenchymal Stem Cells, Placebo)

Completed
  • Alzheimer's Disease
  • Longeveron Mesenchymal Stem Cells
  • Placebo
  • Delray Beach, Florida
  • +2 more
Dec 13, 2021

Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)

Completed
  • Agitation
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +43 more
Oct 29, 2021

Alzheimer's Disease Trial in Worldwide (ALZT-OP1a, ALZT-OP1b, Placebo ALZT-OP1a)

Completed
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +120 more
Nov 8, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Phoenix, Arizona
  • +180 more
Aug 9, 2021

Alzheimer's Disease Trial in United States (AC-1204, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +81 more
Jul 30, 2021

Alzheimer's Disease Trial in Canada, United States (Azeliragon 5mg)

Terminated
  • Alzheimer's Disease
  • Azeliragon 5mg
  • Phoenix, Arizona
  • +70 more
May 28, 2021

Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +114 more
May 6, 2021

Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)

Terminated
  • Alzheimer's Disease
  • Irvine, California
  • +75 more
Mar 22, 2021

Alzheimer's Disease Trial in Worldwide (Elenbecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Chandler, Arizona
  • +257 more
Jan 14, 2021

Agitation Associated With, Alzheimer's Disease, Alzheimer's Type Trial in Worldwide (Brexpiprazole, OPC-34712, Placebo Oral

Completed
  • Agitation Associated With
  • +4 more
  • Brexpiprazole, OPC-34712
  • Placebo Oral Tablet
  • Tuscaloosa, Alabama
  • +84 more
Dec 8, 2020

Alzheimer's Disease Trial in United States (SUVN-502, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +70 more
Nov 20, 2020

Agitation Associated With, Alzheimer's Disease, Alzheimer's Type Trial in Worldwide (Brexpiprazole, OPC-34712)

Completed
  • Agitation Associated With
  • +4 more
  • Brexpiprazole, OPC-34712
  • Imperial, California
  • +70 more
Nov 4, 2020

Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • PET Scan
  • Phoenix, Arizona
  • +30 more
Sep 3, 2020

Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
  • Placebo
  • Tucson, Arizona
  • +31 more
Jul 31, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +195 more
Jul 1, 2020